(Q41707687)

7 October 2017

1 reference

title

Complement inhibitors in myocardial ischemia/reperfusion injury (English)

1 reference

7 October 2017

1 reference

Lucchesi BR

1

1 reference

PubMed ID

9476112

7 October 2017

Kilgore KS

series ordinal

2

1 reference

7 October 2017

1 December 1997

1 reference

7 October 2017

1 reference

7 October 2017

38

1 reference

7 October 2017

27-42

1 reference

7 October 2017

1-2

1 reference

Activation of the complement system by recombinant tissue plasminogen activator

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Potentiation of factor H by heparin: A rate-limiting mechanism for inhibition of the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Scar thinning due to ibuprofen administration after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

C5a-induced expression of P-selectin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Abrupt complement activation and transient neutropenia in patients with acute myocardial infarction treated with streptokinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Complement receptor is an inhibitor of the complement cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Effect of nitroglycerin and ibuprofen on left ventricular topography and rupture threshold during healing after myocardial infarction in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Effects of sulphated polyanions on functions of complement factor H

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Detection of the terminal complement complex in patient plasma following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--II. Effect of polyanions on the binding of C2 to EAC4b

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Immunoglobulin response to intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Structure-function relationships in the inhibitory effect of heparin on complement activation: independency of the anti-coagulant and anti-complementary sites on the heparin molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Membrane signaling by complement C5b-9, the membrane attack complex

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Coronary trapping of a complement activation product (C3a des-Arg) during myocardial reperfusion in open-heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Small heparin fragments regulate the amplification pathway of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Imaging experimental myocardial infarction with indium-111-labeled autologous leukocytes: effects of infarct age and residual regional myocardial blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Effects of the newer nonsteroidal anti-inflammatory agents, ibuprofen, fenoprofen, and sulindac, on neutrophil adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Methylprednisolone and the size of myocardial infarcts

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

Xenografting: probability, possibility, or pipe dream?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

The complement system in the acute phase of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2897%2900060-X

7 January 2021

10.1016/S0162-3109(97)00060-X

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9476112